Organic nitroso compounds
Cayman Chemical N-NItroso SarcosIn-d3 5mg
An internal standard for the quantification of nitroso sarcosine by GC- or LC-MS
Cayman Chemical N-NItroso-N-methylnIlIn 250mg
An N-nitrosamine; induces the formation of esophageal, pharyngeal, and tongue tumors in rats at 200 mg/L in the drinking water or 15 mg/ml via oral gavage; toxic to rats (LD50s = 336 and 225 mg/kg for male and female rats, respectively); reduces survival of hamsters but only induces a low incidence of tumors at 5 mg/week for a total dose of 1.8 mmol
Cayman Chemical N-NItroso-N-ethylnIlIn 10mg
An N-nitrosamine; non-carcinogenic in a survival assay using 2FR450 Rauscher leukemia virus-infected rat embryo cultures; a synthetic intermediate in the synthesis of 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as CXCR2 antagonists
Medchemexpress LLC N-Nitrosomorpholine | 59-89-2 | 100.0% | 1 ML
N-Nitrosomorpholine is a photosensitive nitrosamine that is carcinogenic and can be used to construct animal cancer models. It is for research use only and not sold to patients. High doses of N-Nitrosomorpholine can cause significant cytoplasmic and nuclear changes in livers, leading to toxic damage, single-cell necrosis, loss of glycogen, and induction of giant cell production, bile duct proliferation, and fibrosis. Cirrhosis becomes obvious by the 4th week of treatment, worsening by weeks 15-20, and leading to metastatic liver cancer and death in animals by weeks 30-40.
- Photosensitive nitrosamine
- Carcinogenic agent
- Used for animal cancer model construction
- For research use only
- Induces liver toxicity and cellular changes
- Causes necrosis and fibrosis in liver tissue
- Can lead to metastatic liver cancer and mortality in animals
Sigma Aldrich Fine Chemicals Biosciences N Nitrosodiethylamine NDEA
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
eMolecules 24697-70-9 | 2-(4-hydroxybutyl)isoindoline-1,3-dione | MFCD00204335 | 250mg
Pharmablock | 1-methyl-6-oxo-16-dihydropyridine-2-carboxylic acid | 25mg | 788557060 | PBTQ6717 | 59864-31-2 | MFCD17215908 | 153.137 | C7H7NO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Selleck Chemical LLC N-Nitrosodiethylamine-E0136-5G
N-Nitrosodiethylamine (N-Nitroso-diethylamine NDEA diethylnitrosamine DEN) is DNA reactive after bioactivation and produces tumors in many animal species N-Nitrosodiethylamine can be used to induce animal models of Lung Carcinoma
Selleck Chemical LLC N-Nitrosodiethylamine-E0136-1G
N-Nitrosodiethylamine (N-Nitroso-diethylamine NDEA diethylnitrosamine DEN) is DNA reactive after bioactivation and produces tumors in many animal species N-Nitrosodiethylamine can be used to induce animal models of Lung Carcinoma
Sigma Aldrich Fine Chemicals Biosciences N-Butyl-N-(4-hydroxybutyl)nitrosamine ISOPAC(R), >=90% (GC) | 3817-11-6 | 1G
N-Butyl-N-(4-hydroxybutyl)nitrosamine ISOPAC(R), >=90% (GC) | Purity: >=90% (GC) | Mol Wt: 174.24 | 3817-11-6 | 1G
Medchemexpress LLC S-nitroso-N-acetyl-DL-penicillamine | 67776-06-1 | 98.8% | 5 MG
S-nitroso-N-acetyl-DL-penicillamine (SNAP) is a nitric oxide donor commonly used in biochemical research to provide controlled NO release for studies of vascular function, signaling pathways, and platelet aggregation. It is supplied as a high-purity research chemical for in vitro experiments.
- Releases nitric oxide under physiological conditions.
- Suitable for studies of vasodilation and platelet aggregation.
- High purity (98.8% by HPLC) as confirmed by COA.
- Defined molecular properties: 220.25 g/mol, formula C7H12N2O4S.
- Available in small research pack sizes for laboratory use.
Medchemexpress LLC (R)-PR-924 | 98.5% | 618.72 | 10 MG
(R)-PR-924 is an isomer of PR-924 used as an experimental control. PR-924 is a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor that covalently modifies proteasomal N-terminal threonine active sites. It inhibits growth and triggers apoptosis in multiple myeloma cells, demonstrating antitumor activities.
- Used as an experimental control
- Inhibits growth and triggers apoptosis in multiple myeloma cells
- Covalently modifies proteasomal N-terminal threonine active sites
- Acts as a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor
- Demonstrates antitumor activities
Chemscene ChemScene | N-Nitroso-N-phenylhydroxylamine aluminum salt | 500G | CS-0201281 | 0.98 | 15305-07-4| MFCD00144989 | 438.33
ChemScene | N-Nitroso-N-phenylhydroxylamine aluminum salt | 500G | CS-0201281 | 0.98 | 15305-07-4| MFCD00144989 | 438.33
Medchemexpress LLC N-Nitrosomorpholine | 59-89-2 | 99.98% | 5 G
N-Nitrosomorpholine is a photosensitive nitrosamine that is carcinogenic and can be used to construct animal cancer models. It is for research use only and not sold to patients.
- Photosensitive nitrosamine
- Carcinogenic agent
- Used to construct animal cancer models
- For research use only
- Not sold to patients